Deposition of Aβ42 in the brain is associated with increases in oxidative stress, neuroinflammation, tau hyperphosphorylation, and synaptic dysfunction, as functional biomarkers that correlate with AD onset and progression2–4. This evidence concerns the gene MAPT and Alzheimer disease.